Author

G. P. Taylor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:chromatin & epigenetic regulation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1

Frequent Co-Authors

A. E. N. Aristodemou· 1 shared A. K. Maher· 1 shared C. J. Shaw· 1 shared C. R. M. Bangham· 1 shared C. Selck· 1 shared C.-E. Short· 1 shared D. S. Rueda· 1 shared E. Adem· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. E. N. Aristodemou

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle

A. E. N. Aristodemou, D. S. Rueda, G. P. Taylor, C. R. M. Bangham

This study uses bulk RNA-seq to analyze host gene expression changes during HTLV-1 reactivation in primary CD4+ T cells, identifying Polycomb gene expression shifts and deubiquitinases that promote proviral transcription.

bioRxiv · Jan 8, 2023Microbiology

Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature upon SARS-CoV-2 sensing by monocytes in COVID-19

A. K. Maher, K. L. Burnham, E. Jones, L. Baillon, C. Selck, N. Giang, R. J. Argüello, C.-E. Short, R. Quinlan, W. S. Barclay, N. Cooper, G. P. Taylor, E. E. Davenport, M. Dominguez-Villar

bioRxiv · Apr 3, 2022 · PreprintImmunology

Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV

Y. Takele, T. Mulaw, E. Adem, C. J. Shaw, S. U. Franssen, R. Womersley, M. Kaforou, G. P. Taylor, M. Levin, I. Muller, J. A. Cotton, P. Kropf

The paper identifies three immunological markers that predict visceral leishmaniasis relapse in HIV co-infected patients, showing they are more predictive than clinical features.

bioRxiv · Mar 30, 2021Immunology